Jamison Private Wealth Management Inc. Has $189,000 Stock Position in GE HealthCare Technologies Inc. (NASDAQ:GEHC)

Jamison Private Wealth Management Inc. lessened its holdings in shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 16.3% during the third quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 2,009 shares of the company’s stock after selling 390 shares during the period. Jamison Private Wealth Management Inc.’s holdings in GE HealthCare Technologies were worth $189,000 as of its most recent filing with the SEC.

Several other institutional investors also recently modified their holdings of the business. Global Assets Advisory LLC bought a new position in GE HealthCare Technologies during the 1st quarter worth approximately $4,273,000. Vanguard Group Inc. lifted its holdings in GE HealthCare Technologies by 9.2% in the first quarter. Vanguard Group Inc. now owns 48,519,340 shares of the company’s stock valued at $4,410,893,000 after buying an additional 4,107,746 shares during the period. Mather Group LLC. bought a new stake in GE HealthCare Technologies during the first quarter valued at $106,000. Bank of Montreal Can raised its position in shares of GE HealthCare Technologies by 27.5% in the 2nd quarter. Bank of Montreal Can now owns 696,446 shares of the company’s stock worth $54,964,000 after acquiring an additional 150,137 shares in the last quarter. Finally, Sei Investments Co. lifted its stake in shares of GE HealthCare Technologies by 30.6% in the 1st quarter. Sei Investments Co. now owns 279,336 shares of the company’s stock valued at $25,393,000 after purchasing an additional 65,476 shares during the period. Institutional investors own 82.06% of the company’s stock.

Wall Street Analyst Weigh In

Several research firms recently commented on GEHC. BTIG Research raised GE HealthCare Technologies from a “neutral” rating to a “buy” rating and set a $100.00 target price for the company in a research note on Wednesday, September 18th. Redburn Atlantic raised shares of GE HealthCare Technologies to a “strong-buy” rating in a research note on Thursday, August 1st. JPMorgan Chase & Co. began coverage on shares of GE HealthCare Technologies in a report on Monday, September 9th. They issued a “neutral” rating and a $90.00 price target for the company. Stifel Nicolaus upped their price target on GE HealthCare Technologies from $100.00 to $102.00 and gave the stock a “buy” rating in a research note on Monday, September 30th. Finally, UBS Group cut GE HealthCare Technologies from a “neutral” rating to a “sell” rating and reduced their price objective for the company from $84.00 to $74.00 in a research note on Thursday, September 26th. One research analyst has rated the stock with a sell rating, five have given a hold rating, seven have issued a buy rating and one has assigned a strong buy rating to the company. According to data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and a consensus price target of $94.23.

GE HealthCare Technologies Stock Down 0.5 %

Shares of NASDAQ:GEHC opened at $90.22 on Thursday. GE HealthCare Technologies Inc. has a 1 year low of $62.35 and a 1 year high of $94.55. The company has a market capitalization of $41.18 billion, a PE ratio of 26.38, a price-to-earnings-growth ratio of 3.39 and a beta of 1.18. The business has a fifty day moving average price of $87.58 and a two-hundred day moving average price of $83.36. The company has a debt-to-equity ratio of 1.05, a current ratio of 1.06 and a quick ratio of 0.82.

GE HealthCare Technologies (NASDAQ:GEHC) last posted its quarterly earnings data on Wednesday, July 31st. The company reported $1.00 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.98 by $0.02. GE HealthCare Technologies had a net margin of 8.10% and a return on equity of 25.26%. The business had revenue of $4.84 billion during the quarter, compared to the consensus estimate of $4.88 billion. During the same quarter last year, the company posted $0.92 earnings per share. The firm’s quarterly revenue was up .5% compared to the same quarter last year. Analysts forecast that GE HealthCare Technologies Inc. will post 4.26 earnings per share for the current year.

GE HealthCare Technologies Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Friday, November 15th. Shareholders of record on Friday, October 18th will be paid a $0.03 dividend. The ex-dividend date is Friday, October 18th. This represents a $0.12 annualized dividend and a dividend yield of 0.13%. GE HealthCare Technologies’s payout ratio is presently 3.51%.

Insider Activity

In related news, CEO Thomas J. Westrick sold 2,750 shares of the business’s stock in a transaction dated Wednesday, August 7th. The stock was sold at an average price of $80.78, for a total value of $222,145.00. Following the sale, the chief executive officer now directly owns 17,509 shares in the company, valued at approximately $1,414,377.02. The trade was a 0.00 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Insiders own 0.27% of the company’s stock.

GE HealthCare Technologies Profile

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.